{
    "Trade/Device Name(s)": [
        "Contour Next USB Blood Glucose Monitoring System",
        "Bayer Contour Next USB Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bayer Healthcare LLC",
    "510(k) Number": "K150942",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121087"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "October 29, 2015",
    "Summary Letter Received Date": "October 30, 2015",
    "Submission Date": "November 23, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary whole blood (fingertip and palm)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Contour Next USB blood glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric",
        "Dry reagent test strip"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Contour Next USB Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood at home by persons with diabetes",
    "Indications for Use Summary": "Over-the-counter device for single-patient home use to quantitatively measure glucose in fresh capillary whole blood from fingertip and palm; not intended for diagnosis or screening of diabetes mellitus or for neonates.",
    "fda_folder": "Clinical Chemistry"
}